Get the latest news, insights, and market updates on SRTS (Sensus Healthcare, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
BOCA RATON, Fla., February 18, 2026--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the launch of Sensus Healthcare Financial Services, a new program intended to make it easier for dermatology practices to acquire Sensus’ superficial radiotherapy (SRT) systems through a streamlined process and flexible financing structur Feb 18, 2026 - $SRTS
Sensus Healthcare Q4 Earnings Call Highlights
Sensus Healthcare (NASDAQ:SRTS) used its fourth-quarter and full-year 2025 earnings call to emphasize a major regulatory and reimbursement milestone that management believes reshapes the company’s growth outlook heading into 2026. Executives highlighted newly established, dedicated CPT codes for the Feb 13, 2026 - $SRTS
Sensus Healthcare SRTS Q4 2025 Earnings Transcript
Tirth Patel: As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities laws. All statements other than historical facts that address activities Sensus Healthcare, Inc. assumes, plans, expects, believes, intends, or anticipates, or other similar expressions, will, should, or may occur in the future are forward-looking statements. Feb 12, 2026 - $SRTS
Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026
BOCA RATON, Fla., February 05, 2026--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the company will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and an Feb 5, 2026 - $SRTS
Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco
BOCA RATON, Fla., January 07, 2026--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced that management will be meeting with members of the healthcare investment community January 12–14, 2026, in San Francisco during the 44th Annual J.P. Morgan Healthcare Conference. Jan 7, 2026 - $SRTS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple